These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33139405)
1. The Evolution and Ecology of Resistance in Cancer Therapy. Gatenby RA; Brown JS Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 33139405 [TBL] [Abstract][Full Text] [Related]
2. The Evolution and Ecology of Resistance in Cancer Therapy. Gatenby R; Brown J Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28710258 [TBL] [Abstract][Full Text] [Related]
3. Integrating evolutionary dynamics into cancer therapy. Gatenby RA; Brown JS Nat Rev Clin Oncol; 2020 Nov; 17(11):675-686. PubMed ID: 32699310 [TBL] [Abstract][Full Text] [Related]
4. Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies. Gallaher JA; Enriquez-Navas PM; Luddy KA; Gatenby RA; Anderson ARA Cancer Res; 2018 Apr; 78(8):2127-2139. PubMed ID: 29382708 [TBL] [Abstract][Full Text] [Related]
5. Optimizing Cancer Treatment Using Game Theory: A Review. Stanková K; Brown JS; Dalton WS; Gatenby RA JAMA Oncol; 2019 Jan; 5(1):96-103. PubMed ID: 30098166 [TBL] [Abstract][Full Text] [Related]
7. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution. Kim JY; Gatenby RA Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831 [TBL] [Abstract][Full Text] [Related]
8. Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework. Avner BS; Fialho AM; Chakrabarty AM Bioengineered; 2012; 3(5):262-70. PubMed ID: 22750915 [TBL] [Abstract][Full Text] [Related]
9. Evolutionary dynamics in cancer therapy. Cunningham JJ; Gatenby RA; Brown JS Mol Pharm; 2011 Dec; 8(6):2094-100. PubMed ID: 21815657 [TBL] [Abstract][Full Text] [Related]
10. The role of alternative splicing in cancer: From oncogenesis to drug resistance. Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093 [TBL] [Abstract][Full Text] [Related]
11. Lessons from applied ecology: cancer control using an evolutionary double bind. Gatenby RA; Brown J; Vincent T Cancer Res; 2009 Oct; 69(19):7499-502. PubMed ID: 19752088 [TBL] [Abstract][Full Text] [Related]
12. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
13. Evolution of resistance to anti-cancer therapy during general dosing schedules. Foo J; Michor F J Theor Biol; 2010 Mar; 263(2):179-88. PubMed ID: 20004211 [TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of acquired tumor drug resistance. Aleksakhina SN; Kashyap A; Imyanitov EN Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188310. PubMed ID: 31442474 [TBL] [Abstract][Full Text] [Related]
16. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay. J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522 [TBL] [Abstract][Full Text] [Related]